Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain Management After Total Shoulder Arthroplasty: Continuous Interscalene Block Versus Local Tissue Infiltration With Liposomal Bupivacaine

NCT03219983 is registered in ClinicalTrials.gov with The Christ Hospital as lead sponsor.

NCT NCT03219983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03219983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain Management After Total Shoulder Arthroplasty: Continuous Interscalene Block Versus Local Tissue Infiltration With Liposomal Bupivacaine
Lead sponsor
The Christ Hospital
Phase
Phase 4
Overall status
Terminated
Start date
November 30, 2016
Completion date
September 30, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glenohumeral arthritis, total shoulder arthroplasty